MBRX
Moleculin Biotech, Inc.Company with tickers: MBRX
CIK
1659617
CUSIP
60855D408
Shares Outstanding
5,336,350
Website
https://www.moleculin.com
Investor Relations
https://moleculin.com/investors/
13F Activity (30d)
8 filings
8 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2022-04-08 | — | |
| 8-K/A | 2022-04-12 | 2022-04-08 | |
| DEF 14A | 2022-04-14 | 2022-05-26 | |
| 8-K | 2022-04-21 | — | |
| 8-K | 2022-05-04 | — | |
| 8-K | 2022-05-05 | — | |
| 8-K | 2022-05-10 | — | |
| 10-Q | 2022-05-11 | 2022-03-31 | |
| 8-K | 2022-05-12 | — | |
| 8-K | 2022-05-20 | — | |
| 8-K | 2022-05-26 | — | |
| 8-K | 2022-05-31 | 2022-05-26 | |
| 8-K | 2022-06-09 | — | |
| 8-K | 2022-06-16 | — | |
| 8-K | 2022-07-08 | — | |
| 8-K | 2022-07-28 | — | |
| 10-Q | 2022-08-12 | 2022-06-30 | |
| 8-K | 2022-08-15 | — | |
| 8-K | 2022-08-18 | — | |
| 8-K | 2022-08-19 | — | |
| 8-K | 2022-09-06 | — | |
| 8-K | 2022-09-09 | — | |
| 8-K | 2022-09-27 | — | |
| 8-K | 2022-10-14 | — | |
| 8-K | 2022-11-10 | — | |
| 10-Q | 2022-11-10 | 2022-09-30 | |
| 8-K | 2022-11-14 | 2022-11-10 | |
| 8-K | 2022-12-07 | — | |
| 8-K | 2022-12-15 | — | |
| 8-K | 2022-12-21 | — | |
| 8-K | 2023-02-03 | — | |
| 8-K | 2023-02-08 | — | |
| 8-K | 2023-02-13 | — | |
| 8-K | 2023-03-01 | — | |
| 8-K | 2023-03-09 | — | |
| 8-K | 2023-03-13 | — | |
| 8-K | 2023-03-15 | — | |
| 10-K | 2023-03-22 | 2022-12-31 | |
| 8-K | 2023-03-22 | — | |
| 8-K | 2023-03-23 | — | |
| 8-K | 2023-04-03 | — | |
| DEF 14A | 2023-04-13 | 2023-05-25 | |
| 8-K | 2023-04-18 | — | |
| 8-K | 2023-05-02 | — | |
| 8-K | 2023-05-04 | — | |
| 8-K | 2023-05-05 | — | |
| 10-Q | 2023-05-10 | 2023-03-31 | |
| 8-K | 2023-05-10 | — | |
| 8-K | 2023-05-11 | — | |
| 8-K | 2023-05-12 | — |
Showing 101–150 of 321 filings